- Home
- BSX vs PFE Comparison
BSX vs PFE Comparison
Compare BSX & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- PFE
- Stock Information
- Founded
- BSX 1979
- PFE 1849
- Country
- BSX United States
- PFE United States
- Employees
- BSX N/A
- PFE N/A
- Industry
- BSX Medical/Dental Instruments
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- BSX Health Care
- PFE Health Care
- Exchange
- BSX Nasdaq
- PFE Nasdaq
- Market Cap
- BSX 152.7B
- PFE 142.5B
- IPO Year
- BSX 1992
- PFE N/A
- Fundamental
- Price
- BSX $106.42
- PFE $25.05
- Analyst Decision
- BSX Strong Buy
- PFE Hold
- Analyst Count
- BSX 22
- PFE 12
- Target Price
- BSX $118.32
- PFE $29.36
- AVG Volume (30 Days)
- BSX 6.2M
- PFE 43.6M
- Earning Date
- BSX 10-22-2025
- PFE 08-05-2025
- Dividend Yield
- BSX N/A
- PFE 6.90%
- EPS Growth
- BSX 36.90
- PFE N/A
- EPS
- BSX 1.68
- PFE 1.89
- Revenue
- BSX $18,494,000,000.00
- PFE $63,833,000,000.00
- Revenue This Year
- BSX $19.75
- PFE N/A
- Revenue Next Year
- BSX $10.98
- PFE N/A
- P/E Ratio
- BSX $63.32
- PFE $13.16
- Revenue Growth
- BSX 21.44
- PFE 13.53
- 52 Week Low
- BSX $78.90
- PFE $20.92
- 52 Week High
- BSX $108.94
- PFE $30.43
- Technical
- Relative Strength Index (RSI)
- BSX 57.52
- PFE 52.71
- Support Level
- BSX $104.67
- PFE $24.87
- Resistance Level
- BSX $106.69
- PFE $26.11
- Average True Range (ATR)
- BSX 1.53
- PFE 0.38
- MACD
- BSX 0.29
- PFE 0.02
- Stochastic Oscillator
- BSX 94.28
- PFE 47.69
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.